Search results
Apr 16, 2024 · Read about treatments your healthcare provider might recommend if you have a COVID-19 infection and are receiving treatment at home or at the hospital. Symptoms, testing, what to do if sick, daily activities, and more.
Mar 27, 2024 · Coronavirus disease 2019 (COVID-19) is an illness caused by the virus SARS-CoV-2. Learn more about the symptoms, risks and ways to protect yourself.
Aug 18, 2023 · Tixagevimab and cilgavimab are potent anti-spike neutralizing monoclonal antibodies obtained from antibodies isolated from B cells of patients infected with SARS-CoV-2 that have demonstrated neutralizing activity against SARS-CoV-2 virus by binding to nonoverlapping epitopes of the viral spike-protein RBD.
- Marco Cascella, Michael Rajnik, Arturo Cuomo, Scott C. Dulebohn, Raffaela Di Napoli
- 2023/08/18
- 2020
Dec 20, 2023 · Take precautions to avoid infection. The CDC provides information on the prevention of COVID-19 in people who are immunocompromised. Be tested for SARS-CoV-2 infection if they experience signs and symptoms consistent with COVID-19 and, if infected, promptly seek medical attention.
This section contains recommendations for managing hospitalized children with MIS-C. The guidelines for the diagnosis, treatment, and control of the coronavirus disease 2019 (COVID-19).
Nov 27, 2020 · This review has highlighted reported curative antiviral drugs and broad-spectrum antibiotics (both traditional and orthodox) used in the treatment of SARS-CoV-2; their chemistry, botanical sources, and active components as well as possible clinical trials and safety information.
Feb 29, 2024 · Monoclonal antibodies (mAbs) that target the SARS-CoV-2 spike protein have been shown to have clinical benefits in treating SARS-CoV-2 infection. However, laboratory studies have found that the activity of anti-SARS-CoV-2 mAbs against specific variants and subvariants can vary dramatically.
